Literature DB >> 165244

Cervical cytomegalovirus excretion in pregnant and nonpregnant women: suppression in early gestation.

S Stagno, D Reynolds, A Tsiantos, D A Fuccillo, R Smith, M Tiller, C A Alford.   

Abstract

Comparison of 659 pregnant and 202 nonpregnant women with similar demographic characteristics showed overall rates of cervical cytomegalovirus excretion that were identical (9.5% vs. 9.4%) and were surprisingly high, especially since 89% of the pregnant group possessed antibody to cytomegalovirus when admitted to the study. Prevalence of cytomegalovirus among gravidas was significantly lower during the first (1.6%) than during the third (11.3%) trimester. Thus, early pregnancy appeared to exert a suppressive effect on viral excretion that waned with advancing gestation. A similar but less significant occurrence was observed in the two groups with respect to viuria. Increasing age also appeared to suppress the virologic expression of cervical and urinary tract infection, whereas multiparity seemingly produced such an effect only in the cervix. Among both cervical and urinary excreters, a few shed virus thoughout pregnancy, and others shed virus intermittently; however, viral shedding most commonly began in late gestation and frequently continued into the postpartum period. Primary infection was not documented, and antibody status remained unchanged with the advent of viral excretion in most cases. Thus, reactivation of endogenous virus seems the most likely explanation for viral shedding in our population. Similar rates of isolation of Neisseria gonorrhoeae in excreters and nonexcreters further argue against the other major possibility, venereal reinfection.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165244     DOI: 10.1093/infdis/131.5.522

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity.

Authors:  Lenore Pereira; Ekaterina Maidji; Susan McDonagh; Olga Genbacev; Susan Fisher
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  [Cytomegaloviruses in the amniotic fluid during asymptomatic infection in the mother with transmission to the fetus].

Authors:  R Skvorc-Ranko; J N Gagnon; F Teasdale; M Fauvel; A Chagnon
Journal:  Can Med Assoc J       Date:  1979-09-22       Impact factor: 8.262

Review 3.  Herpesviruses.

Authors:  M C Timbury; E Edmond
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

4.  A comparison of complement fixation, indirect immunofluorescence for viral late antigens, and anti-complement immunofluorescence tests for the detection of cytomegalovirus specific serum antibodies.

Authors:  P D Griffiths; K J Buie; R B Heath
Journal:  J Clin Pathol       Date:  1978-09       Impact factor: 3.411

5.  Infectious mononucleosis and mononucleosis syndromes.

Authors:  M Fiala; D C Heiner; J A Turner; B Rosenbloom; L B Guze
Journal:  West J Med       Date:  1977-06

Review 6.  The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.

Authors:  J B Hudson
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

7.  Alteration of the growth of cytomegalovirus and herpes simplex virus type 1 by epidermal growth factor, a contaminant of crude human chorionic gonadotropin preparations.

Authors:  G E Knox; D W Reynolds; S Cohen; C A Alford
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

Review 8.  Cytomegalovirus infection in the neonate and its prevention.

Authors:  H Stern
Journal:  Postgrad Med J       Date:  1977-10       Impact factor: 2.401

9.  Evaluation of anti-complement immunofluorescence test in cytomegalovirus infection.

Authors:  N Rao; D T Waruszewski; J A Armstrong; R W Atchison; M Ho
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

10.  Comparative activity of immunofluorescent antibody and complement-fixing antibody in cytomegalovirus infection.

Authors:  R F Betts; S D George; R B Rundell; R B Freeman; R G Douglas
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.